CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents.
Front Pharmacol
; 8: 933, 2017.
Article
in En
| MEDLINE
| ID: mdl-29311935
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Pharmacol
Year:
2017
Document type:
Article
Affiliation country:
China
Country of publication:
Switzerland